Kiniksa Pharmaceuticals International (KNSA) Receivables - Net (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Receivables - Net of $23.49 million for Q2 2026, down 26.4% from $31.91 million a year earlier but up 1.1% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Receivables - Net (2021 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International posted Receivables - Net of $15.59 million, down 62.6% from FY2024.
- Receivables - Net has a four-year compound annual growth rate of 40.6% (FY2021 to FY2025).
- By year, Receivables - Net came in at $41.72 million in FY2024 (+96.2%), $21.27 million in FY2023 (+68.0%), $12.66 million in FY2022 (+217.7%) and $3.99 million in FY2021.
- Five-year quarterly Receivables - Net spans a low of $3.04 million in Q3 2023 and a high of $51.74 million in Q3 2025.
- Year over year, Receivables - Net has now declined in each of the last three quarters, with growth averaging 124.7% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q3 2024 (growth of 718.4%); the low point was Q1 2023 (a decline of 74.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $23.22 million (Q1 2026), $15.59 million (Q4 2025) and $51.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Kiniksa Pharmaceuticals International | 6.18 Bn | 4.92 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.49 Mn |
| Mar 31, 2026 | 23.22 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 51.74 Mn |
| Jun 30, 2025 | 31.91 Mn |
| Mar 31, 2025 | 40.07 Mn |
| Dec 31, 2024 | 41.72 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 21.27 Mn |
| Sep 30, 2023 | 3.04 Mn |
| Jun 30, 2023 | 24.65 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 12.66 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 7.81 Mn |
| Mar 31, 2022 | 29.44 Mn |
| Dec 31, 2021 | 3.99 Mn |
| Sep 30, 2021 | 3.22 Mn |
API Access
Kiniksa Pharmaceuticals International Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();